| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
49,160,000 |
| Market
Cap: |
313.64(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.14 - $13.81 |
|
| Level
I Sector: |
Financials |
| Level
II Sector: |
Financial Services |
| Level
III Sector: |
Diversified Investments |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Co.'s primary product candidate, pemvidutide (proposed INN), is a good laboratory practices-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and non-alcoholic steatohepatitis. In addition, Co. is developing HepTcell, an immunotherapeutic agent designed to achieve a functional cure for chronic hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
300 |
30,300 |
| Total Buy Value |
$0 |
$0 |
$863 |
$132,633 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
1 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
155,302 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,133,902 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
9 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pappajohn John |
Chairman and Secretary |
• • – |
2007-08-07 |
4/A |
B |
$7.70 |
$462,000 |
D/D |
60,000 |
1,142,000 |
2.81 |
- |
|
| Schaffer Derace L |
Former Officer and Director |
– – – |
2007-08-07 |
4 |
B |
$7.70 |
$308,000 |
D/D |
40,000 |
1,022,000 |
2.44 |
- |
|
| Simon Nicholas J III |
10% Owner |
– – • |
2007-08-07 |
4 |
B |
$7.70 |
$962,500 |
I/I |
125,000 |
3,468,250 |
1.5 |
- |
|
| Mpm Asset Management Investors 2004 Bviii Llc |
10% Owner |
– – • |
2007-08-07 |
4 |
B |
$7.70 |
$962,500 |
I/I |
125,000 |
3,468,250 |
1.5 |
- |
|
| Cavanaugh James H |
Director |
– • • |
2007-08-06 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,317,243 |
|
- |
|
| Czerepak Elizabeth |
Director |
– • – |
2007-08-06 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,320,087 |
|
- |
|
| Mccleary Joel |
Director |
– • – |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
101,411 |
|
- |
|
| Czerepak Elizabeth |
Director |
– • – |
2007-08-06 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,320,065 |
|
- |
|
| Riddle Valerie D |
VP, Medical DirectorOfficer |
• – – |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,821 |
|
- |
|
| Cook Francesca M |
VP, Policy & Govt AffairsOffic |
• – – |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,102 |
|
- |
|
| Czerepak Elizabeth |
Director |
– • – |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,311,451 |
|
- |
|
| Cavanaugh James H |
Director |
– • • |
2007-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,297,174 |
|
- |
|
| Miraelli Christopher |
10% Owner |
– – • |
2007-08-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,067,243 |
3,317,243 |
|
- |
|
| Miraelli Christopher |
10% Owner |
– – • |
2007-08-03 |
4/A |
B |
$7.66 |
$957,500 |
D/D |
125,000 |
250,000 |
2.45 |
- |
|
| Simon Nicholas J III |
10% Owner |
– – • |
2007-08-03 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,239,443 |
3,364,443 |
|
- |
|
| Mpm Asset Management Investors 2004 Bviii Llc |
10% Owner |
– – • |
2007-08-03 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,239,443 |
3,364,443 |
|
- |
|
| Wright David P |
Chief Executive OfficerMember |
• • – |
2007-08-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,541 |
100,541 |
|
- |
|
| Mpm Asset Management Investors 2004 Bviii Llc |
|
– – – |
2007-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
125,000 |
|
- |
|
| Simon Nicholas J III |
|
– – – |
2007-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
125,000 |
|
- |
|
| Englander Israel A |
10% Owner |
– – • |
2007-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,200,000 |
|
- |
|
| Wright David P |
Chief Executive OfficerOffice |
• – – |
2007-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,542 |
|
- |
|
| Wright David P |
Chief Executive Officermember |
• – – |
2007-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,542 |
100,542 |
|
- |
|
| Simon Nicholas J III |
10% Owner |
– – • |
2007-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,218,250 |
3,343,250 |
|
- |
|
| Mpm Asset Management Investors 2004 Bviii Llc |
10% Owner |
– – • |
2007-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,218,250 |
3,343,250 |
|
- |
|
| Aguiar Eric |
10% Owner |
– – • |
2007-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,047,174 |
3,297,174 |
|
- |
|
417 Records found
|
|
Page 15 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.10 (1.54%) 
